LC determination of octreotide acetate in compound formulations of Sandostatin and diamorphine hydrochloride

J Pharm Biomed Anal. 1999 Nov;21(2):327-30. doi: 10.1016/s0731-7085(99)00123-5.

Abstract

The determination of octreotide acetate in compound formulations of Sandostatin and diamorphine hydrochloride by RP-LC is described. Octreotide acetate, diamorphine hydrochloride and their respective degradants, [des-Thr-ol8]-octreotide and 6-O-acetylmorphine, were baseline resolved using a Lichrospher-60 RP-select B column with a mobile phase composition of acetonitrile/phosphate buffer (pH 7.4, 20 mM) (35:65 v/v) with UV detection at 210 nm. The method is simple, selective, precise and suitable for the determination of octreotide acetate in admixture.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Buffers
  • Chemistry, Pharmaceutical
  • Chromatography, High Pressure Liquid / methods
  • Drug Combinations
  • Heroin / analysis*
  • Heroin / chemistry
  • Hydrogen-Ion Concentration
  • Molecular Structure
  • Octreotide / analysis*
  • Octreotide / chemistry

Substances

  • Buffers
  • Drug Combinations
  • Heroin
  • Octreotide